Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: A newly described paraneoplastic autoimmune disorder with fatal clinical course

Clinical and Experimental Immunology

Volumn 166, Issue 2, 2011, Pages 164-170

  Hanafusa, T ^a   Azukizawa, H ^a   Kitaba, S ^a   Murota, H ^a   Umegaki, N ^a   Terao, M ^a   Sano, S ^b   Nakagiri, T ^a   Okumura, M ^a   Katayama, I ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Autoimmunity; Graft versus host disease (GVHD); Regulatory T cells; Th17; Thymus

Indexed keywords

AMBENONIUM; CYCLOSPORIN; DOCETAXEL; PREDNISOLONE; STEROID; TACROLIMUS;

ABLATION THERAPY; ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DIARRHEA; DISEASE COURSE; DISSEMINATED CANCER; DRUG MEGADOSE; EPIDERMIS; ERYTHEMA; ERYTHRODERMA; FEMALE; GLOSSITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; LIVER DYSFUNCTION; LYMPH NODE METASTASIS; MYASTHENIA GRAVIS; NEEDLE BIOPSY; OVARIECTOMY; PARANEOPLASTIC PEMPHIGUS; PERITONEUM TUMOR; PLEURA CAVITY; PNEUMONIA; PRIORITY JOURNAL; PSORIASIS VULGARIS; PTOSIS; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; SEPSIS; SKIN BIOPSY; SKIN DEFECT; SKIN INFILTRATE; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; THYMECTOMY; THYMOMA; TUMOR VOLUME;

ADULT; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LYMPHOCYTE COUNT; PSORIASIS; SKIN; SKIN DISEASES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; THYMOMA; THYMUS GLAND; TUMOR MICROENVIRONMENT;

EID: 80053638955     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04472.x     Document Type: Article

References (34)

1. Kornacki S, Hansen FC III, Lazenby A. Graft-versus-host-like colitis associated with malignant thymoma. Am J Surg Pathol 1995; 19:224-8.
2. Holder J, North J, Bourke J etal. Thymoma-associated cutaneous graft-versus-host-like reaction. Clin Exp Dermatol 1997; 22:287-90.
3. Wang MH, Wong JM, Wang CY. Graft-versus-host disease-like syndrome in malignant thymoma. Scand J Gastroenterol 2000; 35:667-70.
4. Sader C, Sharma S, Edwards MG. Graft-versus-host disease-type colitis: an unusual association of malignant thymoma. Ann Thorac Surg 2002; 73:1947-8.
5. Lowry PW, Myers JD, Geller A, Bostwick DG, Clain JE. Graft-versus-host-like colitis and malignant thymoma. Dig Dis Sci 2002; 47:1998-2001.
6. Sleijfer S, Kaptein A, Versteegh MI, Hegt VN, Snels DG, van Tilburg AJ. Full-blown graft-versus-host disease presenting with skin manifestations, jaundice and diarrhoea: an unusual paraneoplastic phenomenon of a thymoma. Eur J Gastroenterol Hepatol 2003; 15:565-9.
7. Nakagiri T, Okumura M, Inoue M etal. Thymoma-associated graft-versus-host disease-like erythroderma. J Thorac Oncol 2007 2:1130-2.
8. Wadhera A, Maverakis E, Mitsiades N, Lara PN, Fung MA, Lynch PJ. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. J Am Acad Dermatol 2007; 57:683-9.
9. Offerhaus GJ, Schipper ME, Lazenby AJ etal. Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity? Immunol Lett 2007; 114:31-7.
10. Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 2003; 56:12-16.
11. Hanafusa T, Umegaki N, Yamaguchi Y, Katayama I. Good's syndrome (hypogammaglobulinemia with thymoma) presenting intractable opportunistic infections and hyperkeratotic lichen planus. J Dermatol 2010; 37:171-4.
12. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373:1550-61.
13. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006; 24:209-26.
14. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
15. Miura Y, Thoburn CJ, Bright EC etal. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004; 104:2187-93.
16. Edinger M, Hoffmann P, Ermann J etal. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9:1144-50.
17. Stanzani M, Martins SL, Saliba RM etal. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood 2004; 103:1140-6.
18. Fondi C, Nozzoli C, Benemei S etal. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol Blood Marrow Transplant 2009; 15:938-47.
19. Dander E, Balduzzi A, Zappa G etal. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009; 88:1261-72.
20. Moran CA, Suster S. The World Health Organization (WHO) histologic classification of thymomas: a reanalysis. Curr Treat Options Oncol 2008; 9:288-99.
21. Roncador G, Brown PJ, Maestre L etal. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005; 35:1681-91.
22. Rensing-Ehl A, Gaus B, Bruckner-Tuderman L, Martin SF. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid. Exp Dermatol 2007; 16:13-21.
23. Murphy GF, Merot Y, Tong AK, Smith B, Mihm MC Jr. Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans. J Invest Dermatol 1985; 84:210-14.
24. Perreault C, Pelletier M, Landry D, Gyger M. Study of Langerhans cells after allogeneic bone marrow transplantation. Blood 1984; 63:807-11.
25. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol 2005; 5:772-82.
26. Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol 2006; 24:571-606.
27. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2:1032-9.
28. Anderson MS, Venanzi ES, Klein L etal. Projection of an immunological self shadow within the thymus by the Aire protein. Science 2002; 298:1395-401.
29. Okumura M, Fujii Y, Shiono H etal. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg 2008 56:143-50.
30. Klein S, Kretz CC, Ruland V etal. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma. Ann Rheum Dis 2010; 70:1475-81.
31. Antiga E, Quaglino P, Bellandi S etal. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 2010; 162:1056-63.
32. Maeda Y, Levy RB, Reddy P etal. Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood 2005; 105:2023-7.
33. Asarch A, Barak O, Loo DS, Gottlieb AB. Th17 cells: a new paradigm for cutaneous inflammation. J Dermatol Treat 2008; 19:259-66.
34. Lowes MA, Kikuchi T, Fuentes-Duculan J etal. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128:1207-11.